3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-[3-(dimethylamino)propyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine HCl
3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-[3-(dimethylamino)propyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine HCl
| SMILES |
CN(C)CCCN=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4.Cl |
| InChIKey |
YTCBTFMGKDZRBD-UHFFFAOYSA-N |
Chemical Properties
| Hydrogen bond acceptors |
5 |
| Hydrogen bond donors |
1 |
| Rotatable bonds |
8 |
| Molecular weight (Da) |
593.1 |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-[3-(dimethylamino)propyl]-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine HCl
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.